Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer.

Symmons, Deborah P M

Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer. [electronic resource] - Arthritis and rheumatism Jun 2004 - 1703-6 p. digital

Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't; Review

0004-3591

10.1002/art.20312 doi


Antirheumatic Agents--adverse effects
Arthritis, Rheumatoid--drug therapy
Humans
Lymphoma--epidemiology
Risk Factors
Tumor Necrosis Factor-alpha--antagonists & inhibitors